Insights
Research and Clinical Trial Topics
Webinar Replay: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments
Dr. Peter Cho section on Cough in ILDs from 28:52 - 39:40. Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to progressive respiratory impairment and respiratory...
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects' cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Why the Tegaderm™ Adhesive is a Trusted, Patient-Friendly Solution for the RESP® Biosensor
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection with wearables and devices. At Strados Labs, we understand the importance of these factors with the RESP® Biosensor, which is designed to continuously...
Cough as an Endpoint in IPF Trials: Why it Matters
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients...
Leicester Cough Questionnaire: An Overview
The Leicester Cough Questionnaire (LCQ)1 is a self-reporting tool developed by S.S. Birring and others to evaluate the impact of chronic cough on a patient's quality of life. Chronic cough,2 which impacts between 10-20% of the US population,3 is a cough that can last...
Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant
In November 2023, Merck's chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough (RCC) or...
Healthcare and Remote Patient Monitoring Topics
Q/A with Dr. Henry Schmidt: Principal Investigator of Strados Labs’ Pediatric Asthma Study with Lurie Children’s
Dr. Henry Schmidt was the principal investigator for Strados Labs’ recent pediatric asthma study in partnership with Ann and Robert H. Lurie Children’s Hospital of Chicago which was completed earlier this year. The Strados team was fortunate to meet for a short...
An Interview with Strados Labs Founder Nick Delmonico Featured in Respiratory Therapy Magazine
Respiratory Therapy Magazine recently sat down with Nick Delmonico, CEO of Strados Labs, to discuss the RESP® Biosensor, an innovative wearable device designed to continuously capture lung sounds such as coughs, wheeze, and crackles. In this Q&A, Delmonico shares...
COPD Lung Sounds: An Overview & What They Mean
Chronic Obstructive Pulmonary Disease (COPD), a combination of chronic bronchitis and emphysema that affects the respiratory system, can lead to certain adventitious (or abnormal) lung sounds often associated with exacerbations. While these sounds may be alarming,...
COPD Remote Patient Monitoring: Overview & New Technologies
Chronic obstructive pulmonary disease (COPD) affects many people globally, causing distress to patients and families and burdening healthcare systems. It is a challenging disease to manage. According to studies, COPD hospitalizes approximately 700,000 individuals in...
How Monitoring Lung Sounds Could Reduce Hospital Visits in Future ‘Tripledemic’ Winters
You saw it in the news this winter - the country experienced a tripledemic of the flu, respiratory syncytial virus (RSV) and Covid-19. According to The Hill, 40% of US households have had someone infected with at least one of these respiratory viruses, experiencing...
Subscribe
Get notified whenever we publish a new blog, video or whitepaper